Total thyroidectomy in the mouse: The feasibility study in the non-thyroidal tumor model expressing human sodium/iodide symporter gene

Nuclear Medicine and Molecular Imaging

Volumn 45, Issue 2, 2011, Pages 103-110

  Shim, Hye Kyung ^a   Kim, Seog Gyun ^a   Kim, Tae Sung ^a   Kim, Seok Ki ^a   Lee, Sang Jin ^a  

^a Hematologic Oncology Clinic   (South Korea)

Author keywords

Human sodium iodide symporter; Mouse; Surgical technique; Total thyroidectomy

Indexed keywords

IODINE 131; PERTECHNETIC ACID TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CANCER MODEL; CONTROLLED STUDY; FEASIBILITY STUDY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IODINE 131 UPTAKE TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SODIUM IODIDE SYMPORTER GENE; SURGICAL MORTALITY; SURGICAL STRESS; SURGICAL TECHNIQUE; SURVIVAL RATE; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

EID: 79960050337     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-011-0076-x     Document Type: Article

References (20)

1. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther. 2007;18:916-24.
2. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, et al. Prostate-specific antigen (PSA) promoterdriven androgen-inducible expression of sodium iodide symporter in prosate cancer cell lines. Cancer Res. 1999;59:2136-41.
3. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Probasin promoter (ARR(2)PB)-driven, prostate specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res. 2003;63:7840-4.
4. Chung JK. Molecular nuclear medicine using sodium/iodide symporter. Int Congr Ser. 2004;1264:77-83.
5. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, Scherf M, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science. 2008;321:956-60.
6. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: The sodium/iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab. 2001;86:3327-35.
7. Sakurai MK, Greene AK, Wilson J, Fauza D, Puder M. Pneumonectomy in the mouse: Technique and perioperative management. J Invest Surg. 2005;18:201-5.
8. Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 1991;51:3753-61.
9. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics. 2004;16:349-60.
10. Palacios-Romero R, Mowbray J. Evidence for the rapid direct control both in vivo and in vitro of the efficiency of oxidative phosphorylation by 3, 5, 3'-tri-iodo-L-thyronine in rats. Biochem J. 1979;184:527-38.
11. Ishibashi S, Takeuchi H, Fujii K, Shiraishi N, Adachi Y, Kitano S. Length of laparotomy incision and surgical stress assessed by serum IL-6 level. Injury. 2006;37:247-51.
12. Takenaka K, Ogawa E, Wada H, Hirata T. Systemic inflammatory response syndrome and surgical stress in thoracic surgery. J Crit Care. 2006;21:48-53.
13. Leung KL, Lai PB, Ho RL, Meng WC, Yiu RY, Lee JF, et al. Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial. Ann Surg. 2000;231:506-11.
14. Nishiguchi K, Okuda J, Toyoda M, Tanaka K, Tanigawa N. Comparative evaluation of surgical stress of laparoscopic and open surgeries for colorectal carcinoma. Dis Colon Rectum. 2001;44:223-30.
15. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
16. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, Rempe L, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med. 1995;21:302-9.
17. Smail N, Messiah A, Edouard A, Descorps-Declère A, Duranteau J, Vigué B, et al. Role of systemic inflammatory response syndrome and infection in the occurrence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med. 1995;21:813-6.
18. Yim AP, Wan S, Lee TW, Arifi AA. VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg. 2000;70:243-7.
19. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg. 2001;72:362-5.
20. Grande M, Tucci GF, Adorisio O, Barini A, Rulli F, Neri A, et al. Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg Endosc. 2002;16:313-6.